Serum Homocysteine Level Is a Predictor of Relapse and Prognosis in Patients With First-Attack Neuromyelitis Optica Spectrum Disorders

Background: Many patients with neuromyelitis optica spectrum disorders (NMOSD) experience the adverse consequences of relapse and disability aggravation. Thus, it is necessary to identify sensitive and reliable biomarkers for early prognosis. This study investigated whether serum homocysteine (Hcy)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Zhang, Jinwei, Li, Yanfei, Zhou, Yongyan, Zhao, Yi, Xie, Haojie, Duan, Ranran, Yao, Yaobing, Gong, Zhe, Teng, Junfang, Jia, Yanjie
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8187771/
https://ncbi.nlm.nih.gov/pubmed/34122309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.667651
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados